MedPath
NMPA Approval

Sucralfate Oral Suspension Gel

国药准字HJ20250052

April 22, 2025

Drug Information

硫糖铝口服混悬凝胶

口服混悬凝胶

5ml:1g

化学药品

April 22, 2025

April 21, 2030

Company Information

Applicant Company

Via Licinio, 11-22036 ERBA (CO)

Manufacturing Company

elementis pharma gmbh(灌装前制剂的生产以及中间体控制);zeta farmaceutici s.p.a.(初级包装)

Giulinistrasse 2-67065 LUDWIGSHAFEN (GERMANIA)(灌装前制剂的生产以及中间体控制);Via Galvani, 10-36066 SANDRIGO (VI)(初级包装)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫糖铝口服混悬凝胶 - NMPA 批准文号 | MedPath